Regeneron Gets Expanded EUA for Covid-19 Antibody Cocktail
July 30 2021 - 02:16PM
Dow Jones News
By Josh Beckerman
Regeneron Pharmaceuticals Inc.'s Covid-19 antibody cocktail has
received an expanded Emergency Use Authorization from the Food and
Drug Administration.
The expanded authorization enables use of REGEN-COV for
post-exposure prophylaxis in certain people exposed to a SARS-CoV-2
infected individual, or who are at high risk of exposure to an
infected person in an institutional setting.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
July 30, 2021 14:13 ET (18:13 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From Feb 2024 to Mar 2024
Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From Mar 2023 to Mar 2024